Evidence map›Paper›PMID 35338170›Full record

ArticleScientific reports2022

Evidence of antagonistic predictive effects of miRNAs in breast cancer cohorts through data-driven networks.

Cesare Miglioli, Gaetan Bakalli, Samuel Orso, Mucyo Karemera, Roberto Molinari, Stéphane Guerrier, Nabil Mili

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Cesare Miglioli *University of Geneva, Geneva School of Economics and Management, Geneva, 1205, Switzerland. cesare.miglioli@unige.ch.
Gaetan BakalliAuburn University, Department of Mathematics and Statistics, Auburn, AL, 36849, USA.
Samuel OrsoUniversity of Geneva, Geneva School of Economics and Management, Geneva, 1205, Switzerland.
Mucyo KaremeraAuburn University, Department of Mathematics and Statistics, Auburn, AL, 36849, USA.
Roberto MolinariAuburn University, Department of Mathematics and Statistics, Auburn, AL, 36849, USA.
Stéphane GuerrierUniversity of Geneva, Geneva School of Economics and Management, Geneva, 1205, Switzerland.
Nabil Mili *University of Lausanne, Lausanne, 1015, Switzerland. nabil.mili@unil.ch.
Auburn University · USUniversity of Geneva · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-coding micro RNAs (miRNAs) dysregulation seems to play an important role in the pathways involved in breast cancer occurrence and progression. In different studies, opposite functions may be assigned to the same miRNA, either promoting the disease or protecting from it. Our research tackles the following issues: (i) why aren't there any concordant findings in many research studies regarding the role of miRNAs in the progression of breast cancer? (ii) could a miRNA have either an activating effect or an inhibiting one in cancer progression according to the other miRNAs with which it interacts? For this purpose, we analyse the AHUS dataset made available on the ArrayExpress platform by Haakensen et al. The breast tissue specimens were collected over 7 years between 2003 and 2009. miRNA-expression profiling was obtained for 55 invasive carcinomas and 70 normal breast tissue samples. Our statistical analysis is based on a recently developed model and feature selection technique which, instead of selecting a single model (i.e. a unique combination of miRNAs), delivers a set of models with equivalent predictive capabilities that allows to interpret and visualize the interaction of these features. As a result, we discover a set of 112 indistinguishable models (in a predictive sense) each with 4 or 5 miRNAs. Within this set, by comparing the model coefficients, we are able to identify three classes of miRNA: (i) oncogenic miRNAs; (ii) protective miRNAs; (iii) undefined miRNAs which can play both an oncogenic and a protective role according to the network with which they interact. These results shed new light on the biological action of miRNAs in breast cancer and may contribute to explain why, in some cases, different studies attribute opposite functions to the same miRNA.

Indexed as

Breast NeoplasmsMicroRNAsCarcinogenesisFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansOncogenesMicroRNAs

Identifiers

PMID35338170
PMCPMC8956684
OpenAlexW4220966620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.